Precera Medical has acquired the assets and business of Additive Metal Services, expanding its manufacturing capabilities for complex precision medical device components.
Additive Metal Services is based in Port Huron, Michigan and specializes in metal injection molding and sinter-based additive manufacturing.
The transaction represents Precera’s first strategic acquisition since SK Capital launched the medical manufacturing platform in November 2025.
The acquisition adds metal injection molding and additive manufacturing to Precera’s existing capabilities in design and process development, rapid prototyping, precision machining, micro-feature machining, automation and finished device assembly.
Precera plans to provide medical device customers with a more integrated manufacturing platform spanning early-stage product development, design for manufacturability, validation and scaled commercial production.
The combined capabilities are particularly relevant for complex medical device components that require tight tolerances and sophisticated manufacturing processes.
Potential applications include robotic surgery end effectors and distal components used in interventional catheter-based devices.
Precera has also invested in production equipment and infrastructure to expand metal injection molding capabilities at its Minnesota operations.
The new capacity is intended to support larger-scale programs requiring automated metal injection molding followed by finished machining.
The process can be particularly useful for components with complex geometries and tight tolerances.
Additive Metal Services founder and Managing Director Mark Ward brings specialized experience in metal injection molding and metal additive manufacturing to the combined platform.
Precera operates four manufacturing facilities, including two in Minnesota and two in France.
Its broader manufacturing capabilities include precision multi-axis machining, Swiss machining, additive manufacturing, finished device assembly and highly automated production.
The company serves medical device OEMs and innovators across markets including surgical robotics, minimally invasive surgery, orthopedics and interventional therapies.
Precera said it plans to continue pursuing strategic acquisitions that add manufacturing capabilities to its medical device platform.
KEY QUOTES:
“This is the first strategic acquisition for Precera as we continue building a new era of precision manufacturing. By bringing together decades of MIM experience and specialized equipment with Precera’s capabilities in precision machining and automation, we are creating a scalable solution for critical components such as robotic surgery end effectors and distal components for interventional catheter-based devices with the tolerances, quality and process control these applications demand.”
Dylan Hushka, CEO of Precera Medical
“This is a unique opportunity to combine AMS’s metal injection molding and metal additive manufacturing capabilities with Precera’s strengths in rapid prototyping, machining and automation and deliver a new level of technical expertise and responsiveness to customers.”
Mark Ward, Founder and Managing Director of Additive Metal Services
